GDRX
GoodRx Holdings Inc

5,967
Mkt Cap
$913.07M
Volume
1.37M
52W High
$5.81
52W Low
$2.66
PE Ratio
31.32
GDRX Fundamentals
Price
$2.62
Prev Close
$2.69
Open
$2.78
50D MA
$3.82
Beta
1.33
Avg. Volume
5.91M
EPS (Annual)
$0.0418
P/B
1.53
Rev/Employee
$1.07M
Loading...
Loading...
News
all
press releases
GoodRx (NASDAQ:GDRX) Sets New 1-Year Low - What's Next?
GoodRx (NASDAQ:GDRX) Reaches New 12-Month Low - Here's Why...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic and Wegovy
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more widely available. First, the launch...
Business Wire·3d ago
News Placeholder
GoodRx (NASDAQ:GDRX) Downgraded by Wall Street Zen to Hold
Wall Street Zen downgraded shares of GoodRx from a "buy" rating to a "hold" rating in a report on Saturday...
MarketBeat·5d ago
News Placeholder
GoodRx Holdings, Inc. $GDRX Shares Purchased by Connor Clark & Lunn Investment Management Ltd.
Connor Clark & Lunn Investment Management Ltd. boosted its position in GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 16.5% in the 2nd quarter, according to the company in its most recent 13F...
MarketBeat·7d ago
News Placeholder
JPMorgan Chase & Co. Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price
JPMorgan Chase & Co. cut their price target on shares of GoodRx from $6.00 to $5.00 and set an "overweight" rating on the stock in a research note on Tuesday...
MarketBeat·8d ago
News Placeholder
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from Analysts
GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) has been assigned a consensus rating of "Hold" from the thirteen research firms that are covering the company, Marketbeat Ratings reports. One...
MarketBeat·9d ago
News Placeholder
TD Cowen Cuts GoodRx (NASDAQ:GDRX) Price Target to $6.00
TD Cowen cut their price target on GoodRx from $7.00 to $6.00 and set a "buy" rating on the stock in a research note on Monday...
MarketBeat·9d ago
News Placeholder
UBS Group Issues Pessimistic Forecast for GoodRx (NASDAQ:GDRX) Stock Price
UBS Group reduced their target price on GoodRx from $4.25 to $4.00 and set a "neutral" rating on the stock in a report on Thursday...
MarketBeat·13d ago
News Placeholder
GoodRx (NASDAQ:GDRX) Issues Earnings Results
GoodRx (NASDAQ:GDRX - Get Free Report) released its quarterly earnings results on Tuesday. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.09 by...
MarketBeat·14d ago
News Placeholder
Here's What Key Metrics Tell Us About GoodRx (GDRX) Q3 Earnings
While the top- and bottom-line numbers for GoodRx (GDRX) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·16d ago

Latest GDRX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.